Faculty

Institution

Unit

Venue

Hari Koul

Louisiana State University Health Sciences Center, New Orleans

Affiliations

School of Medicine

Department Of Interdisciplinary Oncology

Division Of Cancer Biology

Louisiana State University Health Sciences Center, New Orleans

School of Graduate Studies

NoneHari Koul is currently serving as a Interdisciplinary Oncology faculty at Louisiana State University Health Sciences Center, New Orleans.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Hari Koul

Louisiana State University Health Sciences Center, New Orleans

You can click a keyword to filter the displayed items

urology cell biology prostate cancer cancer research tumor biology oncogenes molecular cancer cancer discovery cancer cells carcinogenesis cancer letter pharmacology cell signaling oncology molecular biology medicinal research cancer biology nephrology vascular biology cell death prostatic disease signal transduction molecular physiology redox biology free radical biology cell metabolism erectile dysfunction enzyme inhibition erectile function diabetic rat model sexual medicine cancer genetics epigenetic changes host factors cancer treatment medical virology cellular physiology redox signaling tumor suppressors renal function treatment effects kidney research voiding dysfunction gene delivery endothelial dysfunction renal epithelial cells mutualistic interactions cell interactions reactive oxygen species signaling pathways oncogenic agent innate immune system viral pathogenesis clinical immunology immunochemistry treatment development tumor targeting anti-cancer agents cancer prevention disease progression sexual dysfunction in vivo systems renal care complex interaction hippo pathway suppressor cells granulocytic myeloid elevated levels com crystals cancer progression normal human kidney thioridazine suppresses outgrowth prostate cancer irradiation prostate cancer progression dna synthesis alanine-glyoxylate aminotransferase

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 3629: The Association Between Obesity, Diabetes and Prostate Cancer Aggressiveness in Louisiana Cohort. Cancer Research (2026)

public healthobesity medicineprostate cancer aggressivenesslouisiana cohortcancer careobesity managementobesityabstract 3629epidemiology of cancerprostate cancerhealth sciences

Abstract 574: Exploring the Therapeutic Vulnerability of Castration-Resistant Prostate Cancer via Hippo-Yap/Taz-Tead Signaling.. Cancer Research (2026)

Abstract 6322: Uncovering Causal Protein Markers in Prostate Tissue for Prostate Cancer: A Proteome-Wide Association Study and Functional Validation. Cancer Research (2026)

proteomicsbiomarkersfunctional genomicsomicsproteome researchurologycancer discoverytranslational proteomicsprostatic diseasebiostatisticsprognostic biomarkerscausal protein markersprostate tissueproteomic technologiesprostate cancerclinical proteomics

Cooperative Epigenetic Silencing of Spdef by Prc2/Ezh2-Dependent H3K27Me3 and Dna Methylation in Prostate Cancer. SSRN Electronic Journal (2026)

Abstract 2756: Epigenetic Drivers of Enzalutamide Resistance in Prostate Cancer: Targeting of Dnmts and Ezh2 as Therapeutic Strategies to Overcome Enzalutamide Resistance in Prostate Cancer. Cancer Research (2025)

carcinogenesispharmacologyfuture medicinal chemistrycancer researchmolecular cancertumor biologyurologycancer discoverytherapeutic targetspharmacotherapyradiation oncologyoncologyoncogenesepigeneticscancer letterjama oncologyprostate cancer

Abstract C118: Modulation of Prostate Cancer Microenvironment and Immune Responses by Spdef. Cancer Epidemiology Biomarkers & Prevention (2024)

immunologyprostate cancer microenvironmentmolecular cancerurologyabstract c118cancer immunotherapyprostatic diseasegenitourinary cancersimmune responsescancer cellstumor microenvironmentcancer biologyprostate cancer

Dna Methyl-Transferases (Dnmts) as Potential Therapeutic Vulnerability in Prostate Cancer.. Journal of Clinical Oncology (2024)

Tetrandrine for Targeting Therapy Resistance in Cancer. Current Topics in Medicinal Chemistry (2024)

Abstract 1457: Pdef Restricts Prostate Cancer Cellular Plasticity in Part by Modulating Yap1/Taz-Tead Transcriptional Network. Cancer Research (2023)

carcinogenesisgene expressionmetastasiscancer researchmolecular cancertumor biologyurologycancer discoverytranscription factorsmolecular cell biologyproteome researchmolecular biologyoncogenescancer cellscancer letterprostate cancercell biology

Abstract 1949: Spdef Modulates Transcriptional Output to Regulate Multiple Pathways: Immune and Inflammatory Pathways as Potential Hubs Targeted by Spdef in Rcc 7/T Cells, a Line of Prostate Cancer Cells of African American Origin. Journal of Biological Chemistry (2023)

1
2
3
4
5
16
10 / page

Hari Koul

Louisiana State University Health Sciences Center, New Orleans

Affiliations

School of Medicine

Department Of Interdisciplinary Oncology

Division Of Cancer Biology

Louisiana State University Health Sciences Center, New Orleans

School of Graduate Studies

NoneHari Koul is currently serving as a Interdisciplinary Oncology faculty at Louisiana State University Health Sciences Center, New Orleans.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Hari Koul

Louisiana State University Health Sciences Center, New Orleans

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 3629: The Association Between Obesity, Diabetes and Prostate Cancer Aggressiveness in Louisiana Cohort. Cancer Research (2026)

public healthobesity medicineprostate cancer aggressivenesslouisiana cohortcancer careobesity managementobesityabstract 3629epidemiology of cancerprostate cancerhealth sciences

Abstract 574: Exploring the Therapeutic Vulnerability of Castration-Resistant Prostate Cancer via Hippo-Yap/Taz-Tead Signaling.. Cancer Research (2026)

Abstract 6322: Uncovering Causal Protein Markers in Prostate Tissue for Prostate Cancer: A Proteome-Wide Association Study and Functional Validation. Cancer Research (2026)

Cooperative Epigenetic Silencing of Spdef by Prc2/Ezh2-Dependent H3K27Me3 and Dna Methylation in Prostate Cancer. SSRN Electronic Journal (2026)

Abstract C118: Modulation of Prostate Cancer Microenvironment and Immune Responses by Spdef. Cancer Epidemiology Biomarkers & Prevention (2024)

Dna Methyl-Transferases (Dnmts) as Potential Therapeutic Vulnerability in Prostate Cancer.. Journal of Clinical Oncology (2024)

Tetrandrine for Targeting Therapy Resistance in Cancer. Current Topics in Medicinal Chemistry (2024)

Abstract 1457: Pdef Restricts Prostate Cancer Cellular Plasticity in Part by Modulating Yap1/Taz-Tead Transcriptional Network. Cancer Research (2023)

1
2
3
4
5
16
10 / page